Radiant Innovation (3373) Fair Value & Analysis
Healthcare · TW · Market cap 845M TWD
Risks
Fair value as of: Aug 13, 2026
From 3 valuation models · updated 9 days ago
Share price +0.3% over the past month.
Below-average quality, and screening another 27% overvalued on our models.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (15.29 TWD). The favourable scenario is already priced in.
- Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (8.07 TWD to 15.29 TWD) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 15.85 TWD – 69.47 TWD · fair‑value band 8.07 TWD – 15.29 TWD · the 16.75 TWD price screens above the 12.23 TWD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Radiant Innovation (3373) currently trades at 16.75 TWD, while our model-based Fair Value estimate is 12.23 TWD, implying the stock looks roughly 27.0% overvalued today. The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Radiant Innovation generated revenue of 389M TWD at a net margin of -13.7%. Revenue grew 2.0% year over year. It earns a return on equity of -6.5%. Fundamentals as of Aug 13, 2026
Our scenario range runs from 8.07 TWD (bear case) to 15.29 TWD (bull case); at 16.75 TWD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 22% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside, at -27%, 3373 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 3 models by family
Widest divergence: Asset-Based (11.17 TWD) versus Dividend Discount (7.61 TWD). Highest evidence: Gordon GGM (70).
Notify me when 3373 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 44 · Market factors (momentum, volatility) 43
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Radiant Innovation Inc. engages in the design and development of infrared technology products in Taiwan, Japan, and Germany. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; and CO2 monitors.
Full company description
Radiant Innovation Inc. engages in the design and development of infrared technology products in Taiwan, Japan, and Germany. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; and CO2 monitors. The company also offers industrial infrared thermometers, infrared precision thermal imagers, infrared precision gas monitors and other components. Radiant Innovation Inc. was founded in 1989 and is headquartered in Hsinchu City, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Radiant Innovation reported revenue of 388M TWD in FY2025 versus 985M TWD in FY2021, a compound −20.8%/yr. Reported net income was −60.4M TWD in FY2025.
3373 screens 27% overvalued. Compare with Abbott Laboratories, →
Peer Group
Medical Devices · 362 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $110.91 | $74.79 | -33% |
| Stryker Corporation SYK | $327.70 | $186.28 | -43% |
| Medtronic plc MDT | $90.76 | $65.57 | -28% |
| Boston Scientific Corporation BSX | $50.37 | $38.44 | -24% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥150.63 | ¥147.63 | -2% |
| Shanghai United Imaging Healthcare Co 688271 | ¥110.50 | ¥43.60 | -61% |
| Demant A/S DEMANT | kr 289.60 | kr 161.17 | -44% |
| Getinge AB GETIB | kr 240.60 | kr 192.14 | -20% |
| Sectra AB SECTB | kr 280.00 | kr 66.81 | -76% |
| CLASSYS Inc 214150 | 39,700 KRW | 20,415 KRW | -49% |
Compare Radiant Innovation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Radiant Innovation (3373) overvalued or undervalued?
What is the fair value of 3373?
What is the quality score of 3373?
What is the revenue of Radiant Innovation (3373)?
What is the net profit margin of 3373?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Radiant Innovation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.